Fig 1.
Trial profile.
Fig 2.
Risk of a first breakthrough seizure following a period of at least 12 months remission from seizures whilst on treatment.
Table 1.
Participant demographics for those at risk of a first breakthrough seizure, n (%) unless otherwise stated.
Table 2.
Multivariable model hazard ratios for time to first breakthrough seizure after a period of 12-month remission whilst on treatment.
Fig 3.
Risk of a seizure following a breakthrough seizure.
Table 3.
Participant demographics for those at risk of a seizure, or with a chance of achieving 12-month remission following a first breakthrough seizure, n (%) unless otherwise stated.
Table 4.
Effect estimates from multivariable models–risk of seizure recurrence following first breakthrough seizure (n = 510) and likelihood of achieving 12-month remission following a breakthrough seizure (n = 510).
Fig 4.
Chance of achieving 12 month remission following a breakthrough seizure.